Showing results (571-580 of 6,880) with videos related to
Sort By:
Pageof 688
Leukemia Research|May 14, 2011
A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemiaKosuke Tsuboi, Toshiya Yokozawa, Toru Sakura, et al.Leukemia Research|January 1, 1990
T cells and CD45R expression in B-chronic lymphocytic leukemiaP G Briggs, N Kraft, R C AtkinsLeukemia Research|January 1, 1990
gamma IFN receptor expression in haemic malignanciesR B Watson, D W Galvani, J R Nash, et al.Leukemia Research|March 8, 2011
Translocation t(1;9) is a recurrent cytogenetic abnormality associated with progression of essential thrombocythemia patients displaying the JAK2 V617F mutationAnnette Leon, John F Staropoli, Jesus M Hernandez, et al.Leukemia Research|April 5, 2011
The immune reconstitution after an allogeneic stem cell transplant correlates with the risk of graft-versus-host disease and cytomegalovirus infectionGiovanni F Torelli, Barbarella Lucarelli, Anna P Iori, et al.Leukemia Research|June 3, 2011
Heat shock protein 90 inhibition results in altered downstream signaling of mutant KIT and exerts synergistic effects on Kasumi-1 cells when combining with histone deacetylase inhibitorWenjuan Yu, Jianxiang Wang, Jie Jin, et al.Leukemia Research|May 31, 2011
Amount of bone marrow blasts is strongly correlated to NPM1 and FLT3-ITD mutation rate in AML with normal karyotypeTorsten Haferlach, Ulrike Bacher, Tamara Alpermann, et al.Leukemia Research|January 1, 1990
Characterization of two newly established EBV-containing lymphoblastoid cell lines from patients with myeloid leukemiasY S Chang, L Y Shih, C L Peng, et al.Leukemia Research|January 1, 1990
Establishment of a karyotypically normal B-chronic lymphocytic leukemia cell line; evidence of leukemic origin by immunoglobulin gene rearrangementD Saltman, N S Bansal, F M Ross, et al.Leukemia Research|April 9, 2011
Hematologic improvement and response in elderly AML/RAEB patients treated with valproic acid and low-dose Ara-CM T Corsetti, F Salvi, S Perticone, et al.Pageof 688